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Abstract
Background: The offspring of consanguineous relations have an increased risk of congenital/genetic disorders and 
early mortality. Consanguineous couples and their offspring account for approximately 10% of the global population. 
The increased risk for congenital/genetic disorders is most marked for autosomal recessive disorders and depends on 
the degree of relatedness of the parents. For children of first cousins the increased risk is 2-4%. For individual couples, 
however, the extra risk can vary from zero to 25% or higher, with only a minority of these couples having an increased 
risk of at least 25%. It is currently not possible to differentiate between high-and low-risk couples. The quantity of DNA 
identical-by-descent between couples with the same degree of relatedness shows a remarkable variation. Here we 
hypothesize that consanguineous partners with children affected by an autosomal recessive disease have more DNA 
identical-by-descent than similarly-related partners who have only healthy children. The aim of the study is thus to 
establish whether the amount of DNA identical-by-descent in consanguineous parents of children with an autosomal 
recessive disease is indeed different from its proportion in consanguineous parents who have healthy children only.
Methods/Design: This project is designed as a case-control study. Cases are defined as consanguineous couples with 
one or more children with an autosomal recessive disorder and controls as consanguineous couples with at least three 
healthy children and no affected child. We aim to include 100 case couples and 100 control couples. Control couples 
are matched by restricting the search to the same family, clan or ethnic origin as the case couple. Genome-wide SNP 
arrays will be used to test our hypothesis.
Discussion: This study contains a new approach to risk assessment in consanguineous couples. There is no previous 
study on the amount of DNA identical-by-descent in consanguineous parents of affected children compared to the 
consanguineous parents of healthy children. If our hypothesis proves to be correct, further studies are needed to 
obtain different risk figure estimates for the different proportions of DNA identical-by-descent. With more precise 
information about their risk status, empowerment of couples can be improved when making reproductive decisions.
Background
The offspring of consanguineous relations have an aver-
age increased risk of 2-4% of congenital/genetic disorders
and early mortality. However, on an individual level the
exact risk figure can vary to a great extent.
Global prevalence
The children of consanguineous couples represent a con-
siderable group, since an estimated 10.5% of all children
worldwide have consanguineous parents [1]. This fre-
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Page 2 of 5quency is, however, very unevenly distributed between
countries. In some countries the current percentage of
consanguineous marriages is higher, and may even
exceed 50%, while in many others the percentage does
not surpass 1% [2,3]. Worldwide, every year over 130 mil-
lion infants are born [4], which leads to the conclusion
that the considerable number of 13.5 million of those
children have consanguineous parents.
Autosomal recessive (AR) inheritance
A child affected by an AR disease has inherited a patho-
logical allele from both parents who are carriers of such
an allele. If both parents are carriers, all of their children
have a 25% chance of being affected.
Risk is proportional to degree of relatedness of the parents
The risk of being a carrier couple is on the one hand pro-
portional to the frequency of a pathological allele in the
population, and on the other hand proportional to the
coefficient of inbreeding (F), which is defined as the
probability that a child inherits two identical copies of an
allele from one or more common ancestors. The closer
the partners of a consanguineous couple are related, the
greater the chance that they will have genetic information
identical-by-descent (IBD). When the amount of DNA-
sharing increases, this also increases the chance of shar-
ing a particular pathological allele IBD and therefore the
chance of having affected offspring with an AR disease.
Theoretically, the likelihood that an allele passed on to
the next generation will be an identical copy of the allele
of a common ancestor passed on by the other partner is
1/16 (F = 1/16) for first cousins' offspring, whereas for
second cousins' offspring, this is 1/64. For unions less
closely related than second cousins, the risk of having an
affected child is only marginally increased.
Burden
Studies among first-cousin couples, the most prevalent
type of consanguineous marriage, show that the excess
risk for their offspring of having a significant birth defect
ranges from 1.7-2.8% [5]. The risk for mortality in early
life (i.e. from six months of gestation to an average of ten
years of age) in the offspring of first-cousin marriages is
estimated at 3.5% [1]. For this latter figure it remains diffi-
cult to control for the effects of non-genetic variables.
Causes of mortality that are related to other (sociodemo-
graphic) variables, like maternal illiteracy, maternal age
and birth interval, may, in themselves, lead to a higher
rate of neonatal and early childhood mortality and could
be confounders [1,6]. Considering that over 10% of all
children worldwide have consanguineous parents, com-
bined with the excess risk of 2-4% per first-cousin couple,
the conclusion can be drawn that the global burden of
pre-reproductive mortality and morbidity for the chil-
dren and their families is substantial. The proportion of
first-cousin marriages among consanguineous couples is
estimated to be at least 70% [A.H. Bittles, personal com-
munication]. From this number we can infer that the
extra number of affected children born to first-cousin
parents is approximately 190,000 to 380,000 each year.
The total number of cases due to consanguinity, however,
must be higher, since our estimate does not include the
affected children born to consanguineous parents who
are related in another way.
Only the minority of consanguineous couples have an 
increased risk
If one compares the 2-4% additional risk of congenital/
genetic disorders and/or early death in children of a first-
cousin couple, to the 25% risk of a couple in which both
man and wife are carriers of an AR disorder, one has to
conclude that a maximum of 8-16% of all first-cousin
couples are at high risk (25%; or higher in case of carrier-
ship of more than one disorder), while at least 84-92% of
all first-cousin couples have a normal risk, comparable to
unrelated parents.
Risk assessment in practice
When a consanguineous couple is referred for risk assess-
ment, e.g. to a clinical genetics centre, best practice pre-
scribes that a thorough family history will be taken [5].
For an average non-consanguineous couple, a risk of 2-3%
of having a child with a genetic/congenital disorder is
present. For a first-cousin couple, an additional risk of 2-
4% should be added to this basic risk. The risk can further
increase if a family history for a genetic disorder exists. A
more precise risk estimate for that particular disease can
then be assessed by risk calculation or - if possible and
desired - by carrier testing. If the population of origin of
the couple is known to have a high risk of a specific reces-
sive disorder, carrier screening could be offered as well.
A typical characteristic for AR disorders is the fact that
frequently there are no previous affected members within
the family, since affected family members most often can
be found in only one sibship. When there is no history of
diseases in the family of a consanguineous couple that
comes for preconception counselling, there is still an
additional average risk close to 2-4%. However, it is cur-
rently not possible to determine who is at 25% (or more)
risk, and who has no increased risk. Given this uncer-
tainty, being able to give a more precise risk figure could
have important consequences for counselling.
Stochastic variation
The actual amount of DNA IBD in children of first cous-
ins can be different from the theoretical 1/16 due to a sto-
chastic variation which is caused by the random
recombinations in common ancestral loops. This causes a
significant variability between couples with the same F-
value [7]. A simulation study performed by Leutenegger
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mates of the coefficient of inbreeding derived from whole
genome analyses can be found. For example, at first-
cousin level, individuals with an expected F = 0.0625 can
have from 0.03-0.12 of their genome IBD [8]. Clearly, this
variability could significantly alter the probability that a
recessive disease gene will be expressed.
Variation by hidden ancestral loops
A difference in DNA-sharing may also be present while
comparing couples with a similar inbreeding coefficient
when the estimated coefficient is based on limited avail-
able genealogical data. Distant consanguineous loops
often remain unknown, which can lead to an underesti-
mation of the inbreeding coefficient [9]. Genealogy-
based studies have indicated that after 3-4 generations of
cumulative inbreeding and with multiple loops of consan-
guinity, as would occur in many highly inbred communi-
ties, the progeny of first-cousin unions may have F values
up to 0.1484, which likewise would be expected to signifi-
cantly influence recessive gene expression [10]. The vari-
ability in DNA sharing in practice was also shown by
Woods et al. who studied children with AR disorders
whose parents were consanguineous [11]. By using SNP
analysis, they found that in individuals with a recessive
disease whose parents were first cousins, on average 11%
of their genomes were homozygous, as opposed to the
6.25% one would expect.
Hypothesis
On the basis of the above-mentioned considerations and
observations, we hypothesize that consanguineous par-
ents of a child with an AR disorder will have more DNA
IBD than similarly-related parents who have only had
healthy children. This hypothesis leads to the objective of
our present study, namely to establish whether the
amount of DNA IBD in partners of consanguineous cou-
ples with a child affected by an AR disease is indeed
increased compared to its proportion in partners of con-
sanguineous couples who have healthy children only. If
so, this result might be applied to improve risk assess-
ment in consanguineous couples.
Methods/Design
This project is designed as a case-control study in which
we test whether consanguineous partners (cases) with
children affected by AR diseases indeed share more
DNA, IBD, than consanguineous partners (controls) who
are believed to be related to the same degree, but only
have healthy children. We will do this by making use of
genome wide SNP analysis. For this study, approval was
obtained from the Medical Ethics Committee of the VU
University Medical Center.
Matching
The cases and controls will be matched as closely as pos-
sible to assure that allele frequencies will be valid for both
cases and controls, and to decrease the possibility of false
positive or false negative results caused by hidden con-
sanguinity in previous generations. The best way to do
this is by restricting the search for controls to the same
family, but if no suitable controls can be identified, we
will search for controls from the same clan or ethnic ori-
gin.
Criteria for inclusion and exclusion
A case couple will only be included when the AR nature
of the disorder in the offspring is beyond doubt and the
disorder has not occurred in the family before. The exact
nature of the AR disorders in the children of the cases is
irrelevant, as we will only be testing for the proportion of
DNA-sharing irrespective of which regions of the
genome are identical. For this reason it is possible to
combine results from studies conducted in countries and
populations with different AR disease spectra. The inclu-
sion of control couples is restricted to couples whose off-
spring are not only free from known AR disorders but
also from other diseases in which a role for homozygosity
cannot be excluded. Control couples should have at least
three healthy children. When several control couples are
available for a given case, maximum contrast between
cases and controls can be achieved by selecting the con-
trols with the highest number of children.
Numbers needed
Due to lack of knowledge of the exact means and vari-
ances in identical DNA in the two groups, our power cal-
culation is based on the assumption that for first-cousin
couples, who theoretically have 0.125 of their genome
IBD, a standard deviation of 0.0625 will apply. If half a
standard deviation or more is considered a relevant effect
size, we expect to have sufficient power (90%) by sam-
pling a group of 100 cases and 100 controls. A possible
loss of 15% is taken into consideration in this calculation.
Ascertainment
The recruitment of cases will be done in different medical
centres in our country (the Netherlands) and elsewhere.
We will locate the consanguineous parents of children
with an AR disorder through their treating physicians.
After receiving extensive information from the
researcher, informed consent is obtained. Control cou-
ples, if present in the same families, will be asked to par-
ticipate by an invitational letter given to them by their
participating family members (the cases), or by recruiting
them from the same clan or tribe.
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inbreeding coefficient, but this is not essential, since this
can be corrected for in the calculations.
Pedigree information and family history
Information will be obtained on the identity of all first-
degree-to third-degree family members of both partners
of the index pair. This implies that we try to identify the
great-grandparents of the index pair and all first cousins.
Family members include the deceased, still-born and
miscarriages. For every individual in the family tree, the
health status will be carefully noted. A family tree will be
drawn and saliva will be obtained from the pair. To
increase the amount of information that can be generated
from the DNA of the cases and controls, we will also sam-
ple DNA from the children if possible, or from other fam-
ily members, e.g. grandparents of the children. An
inbreeding coefficient will be calculated according to the
method described by Wright [12].
DNA sampling and analysis
Saliva is collected in the Oragene kit of DNA Genotek.
DNA will be obtained from these kits, and subsequently
we will perform whole genome SNP arrays by making use
of existing platforms of SNP chips.
Statistical Analysis
Using SNP markers, a genotype will be made for every
individual from whom we obtained a saliva sample. Prog-
eny will be used to generate the individual marker infor-
mation. For the analysis, only independent markers will
be used. Estimations of the inbreeding coefficient will be
calculated by using the method as developed by Wang
[13]. This method generates IBD estimates based on the
observed 'identity-by-state' (IBS) sharing between the
partners. For these calculations we plan to use free acces-
sible software. If there is a difference between the couples
in the calculated F-based on genealogical data - we will
correct for this in our analysis.
The significance of the difference in estimated inbreed-
ing coefficient based on genotype-data between our case
couples and our control couples will be determined by
using a paired t-test. If our data do not follow a (log)nor-
mal distribution, we will use the Wilcoxon matched pairs
signed rank sum test.
Discussion
This study's design contains a new molecular approach to
the increased risk in consanguineous couples. In scien-
tific research so far, homozygosity mapping in affected
children of consanguineous couples has been used for
finding causative genes. On the other hand, the above-
mentioned study by Woods et al looked at the amount of
autozygosity in children of consanguineous relationships.
These authors did not investigate whether affected chil-
dren had more homozygous DNA than healthy children
of consanguineous couples who did not have affected
children. As far as we know, no study has been done on
the amount of DNA IBD in the parents, nor has this been
used to assess their risk of having affected children. The
results of this study will contribute to designing future
research, such as the recruitment of a large - if possible,
international - cohort of consanguineous couples before
reproduction. This cohort will allow us to obtain different
risk figure estimates for the different proportions of DNA
IBD. Once such estimates are available, couples will be
able to benefit from reproductive options when informed
more precisely about their risk status.
A limitation in our study design is the definition of our
control couples. We select couples who have at least three
healthy children. The chance that a carrier couple will
have three healthy children, is nevertheless still 42%. Ide-
ally, we would only include couples with much more
healthy children to diminish the risk of carrier couples
among the parents. However, given the size of most pres-
ent-day families, finding matched control families that
have at least three healthy children will be challenging
enough.
Abbrevations
AR: Autosomal Recessive; F: Inbreeding Coefficient; IBD:
Identical-By-Descent; IBS: Identical-By-State; SNP: Sin-
gle Nucleotide Polymorphism;
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